Breast cancer is the second leading cause of death for women worldwide. The
heterogeneity of this disease presents a big challenge in its therapeutic management …

Recent progress in immunobiology has led the way to successful host immunity
enhancement against breast cancer. In triple-negative breast cancer, the combination of …

Breast cancer is a disease encompassing a spectrum of molecular subtypes and clinical
presentations, each with distinct prognostic implications and treatment responses. Breast …

Heterogeneity of the tumor microenvironment (TME) and the lack of a definite targetable
receptor in triple-negative breast cancer (TNBC) has carved a niche for this cancer as a …

Introduction Neoplastic meningitis (NM), also known as leptomeningeal carcinomatosis, is
characterized by the infiltration of tumor cells into the meninges, and poses a significant …

Immunotherapy represents an attractive avenue for cancer therapy due to its tumour
specificity and relatively low frequency of adverse effects compared to other treatment …